View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

Aptalis Pharmaceutical Technologies Releases Two New White Papers

Aptalis Pharmaceutical Technologies has released two new free-to-download white papers on Pharmaceutical Technology.

In the first, ‘Targeting PK and Patient Needs with Versatile, Time-Based Oral Drug Delivery’, Aptalis explores the growing trend among pharmaceutical developers of repositioning existing products across multiple indications, developing alternative dosage forms, or reformulating them to modify pharmacokinetic profiles.

The second white paper, ‘Growing from a Broader Base’, is an article first published by scrip100.com in which Aptalis president John Fraher discusses the direction of his newly enlarged company, formed in 2011 through the merger of Axcan and Eurand.

 

 

 

Dysphagia can affect many people throughout their lifetime and may compromise medication adherence.
For pharmaceutical manufacturers and healthcare providers, non-adherence to medication is a significant concern.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology